Nephros, Inc. NEPH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.91M | 1.74M | 776.00K | 1.19M | 1.48M |
| Total Depreciation and Amortization | 123.00K | 126.00K | 131.00K | 144.00K | 142.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 934.00K | 940.00K | 954.00K | 985.00K | 1.09M |
| Change in Net Operating Assets | -3.88M | -3.46M | -2.21M | -678.00K | 9.00K |
| Cash from Operations | -910.00K | -661.00K | -348.00K | 1.65M | 2.72M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00K | -6.00K | -5.00K | -5.00K | -5.00K |
| Issuance of Common Stock | 290.00K | 290.00K | 290.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 285.00K | 284.00K | 285.00K | -5.00K | -5.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -625.00K | -377.00K | -63.00K | 1.64M | 2.71M |